Home > Insider Trading > Filing (0001179110-21-002796)

Filing Details

Accession Number:: 0001179110-21-002796
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2021-03-03 19:39:52
Reporting Period:: 2021-03-01

Accepted Time:: 2021-03-03 19:39:52
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1477449	Teladoc Health Inc.	TDOC	()	4

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1208500	N Jason Gorevic	C/O Teladoc Health, Inc., 2 Manhattanville Road, Suite 203 Purchase NY 10577	Chief Executive Officer	Yes	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock	Acquisiton	2021-03-01	13,281	$0.00	540,469	No	4	M	Direct
Common Stock	Acquisiton	2021-03-01	13,944	$0.00	554,413	No	4	M	Direct
Common Stock	Disposition	2021-03-02	12,674	$224.28	541,739	No	4	S	Direct
Common Stock	Acquisiton	2021-03-02	9,104	$0.00	550,843	No	4	M	Direct
Common Stock	Acquisiton	2021-03-02	15,476	$0.00	566,319	No	4	M	Direct
Common Stock	Disposition	2021-03-02	30,000	$223.53	536,319	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	M	Direct
No	4	M	Direct
No	4	S	Direct
No	4	M	Direct
No	4	M	Direct
No	4	S	Direct

Reported Derivative Transactions

Show Other Fields >>

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Restricted Stock Units	Disposition	2021-03-01	13,281	$0.00	13,281	$0.00
Common Stock	Performance Stock Units	Disposition	2021-03-01	13,944	$0.00	13,944	$0.00
Common Stock	Restricted Stock Units	Disposition	2021-03-02	9,104	$0.00	9,104	$0.00
Common Stock	Performance Stock Units	Acquisiton	2021-03-02	46,430	$0.00	46,430	$0.00
Common Stock	Performance Stock Units	Disposition	2021-03-02	15,476	$0.00	15,476	$0.00
Common Stock	Restricted Stock Units	Acquisiton	2021-03-02	22,944	$0.00	22,944	$0.00

Remaning Holdings	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
0	No	4	M	Direct
0	No	4	M	Direct
18,207	No	4	M	Direct
46,430	No	4	A	Direct
30,954	No	4	M	Direct
22,944	No	4	A	Direct

Footnotes

Restricted stock units convert to shares of TDOC common stock on a one-for-one basis.
Performance stock units convert to shares of TDOC common stock on a one-for-one basis.
Shares sold to cover the tax withholding obligation in respect of vesting of the reporting person's restricted stock unit and performance stock unit awards.
This transaction was effected pursuant to a Rule 10b5-1 trading plan that was adopted by the reporting person on March 4, 2020.
Represents the weighted average price of transactions ranging from $216.40 to $231.14. The reporting person undertakes to provide, upon request by the SEC staff, the issuer or any security holder of the issuer, full information regarding the number of shares sold at each separate price.
On March 1, 2018, the reporting person was granted 39,842 restricted stock units, vesting in three substantially equal annual installments beginning on the first anniversary of the grant date.
On March 4, 2019, the reporting person earned 41,834 performance stock units, vesting in three substantially equal annual installments beginning on March 4, 2019 and March 1 each subsequent year.
On March 2, 2020, the reporting person was granted 27,311 restricted stock units, vesting in three substantially equal annual installments beginning on the first anniversary of the grant date.
The performance stock units vest in three substantially equal annual installments beginning on March 2, 2021.
On March 2, 2021, the reporting person earned 46,430 performance stock units, vesting in three substantially equal annual installments beginning on March 2, 2021.
Each performance stock unit represents a contingent right to receive one share of TDOC common stock.
Each restricted stock unit represents a contingent right to receive one share of TDOC common stock.
The restricted stock units vest in three substantially equal annual installments beginning on the first anniversary of the grant date.
Performance award amount determined based on metrics in respect of the issuer's 2020 financial results.